Rajiv Amin
Geen lopende functies
Vermogen: - $ op 31-03-2024
Profiel
Rajiv Amin worked as a Senior Director of Financial Reporting at Alvogen, Inc. and Kyowa Kirin, Inc. He also worked as a Controller-Americas at Convatec Group Plc.
Amin received his undergraduate degree from the University of Scranton and his graduate degree from Babson College.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 10-03-2023 | 0 ( -.--% ) | - $ | 31-03-2024 |
Eerdere bekende functies van Rajiv Amin
| Bedrijven | Functie | Einde |
|---|---|---|
Alvogen, Inc.
 Alvogen, Inc. Pharmaceuticals: MajorHealth Technology Alvogen, Inc. develops, manufactures, and distributes generic pharmaceutical products. The firm's business include product development, contract manufacturing and research, sales of generic medicines, bio-similar, and over the counters. Its product portfolio consists of molecules for the treatment of conditions in the fields of oncology, cardiology, respiratory, neurology and gastroenterology. The company was founded by Robert Wessman in 2009 and is headquartered in Pine Brook, NJ. | Corporate Officer/Principal | - |
| Kyowa Kirin, Inc. | Corporate Officer/Principal | - |
| CONVATEC GROUP PLC | Corporate Officer/Principal | - |
| IPI LEGACY LIQUIDATION CO | Financieel Directeur/CFO | 10-05-2023 |
Opleiding van Rajiv Amin
| Babson College | Graduate Degree |
| University of Scranton | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| IPI LEGACY LIQUIDATION CO | Health Technology |
| CONVATEC GROUP PLC | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
| Kyowa Kirin, Inc. | |
Alvogen, Inc.
Alvogen, Inc. Pharmaceuticals: MajorHealth Technology Alvogen, Inc. develops, manufactures, and distributes generic pharmaceutical products. The firm's business include product development, contract manufacturing and research, sales of generic medicines, bio-similar, and over the counters. Its product portfolio consists of molecules for the treatment of conditions in the fields of oncology, cardiology, respiratory, neurology and gastroenterology. The company was founded by Robert Wessman in 2009 and is headquartered in Pine Brook, NJ. | Health Technology |
